Salwa J
Department of Tumor Immunology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
Arch Immunol Ther Exp (Warsz). 1995;43(1):37-41.
The cytotoxic and cytostatic activity of PMA-treated macrophages, obtained from pristane-primed BALB/c mice, was analyzed in vitro. The activated macrophages were cytotoxic and cytostatic for YAC-1 lymphoma, P-388 leukemia and P-815 mastocytoma target cells. However, the RPC-5 plasmacytoma target cells appeared to be resistant to their cytotoxicity. The observed cytotoxic or cytostatic effects of macrophages in vitro were not correlated with their ability to produce the superoxide ion. Cytotoxic activity of NK cells, obtained from pristane-primed mice, was also studied. No differences in cytotoxicity of NK cells obtained from pristane-treated and untreated donors, were found. However, only the effector cells from untreated mice were able to respond to stimulatory effect of polyinosinic acid-polycytidylic acid-poly-L-lysine (poly ICLC).
对从经 pristane 预处理的 BALB/c 小鼠获得的经 PMA 处理的巨噬细胞的细胞毒性和细胞生长抑制活性进行了体外分析。活化的巨噬细胞对 YAC-1 淋巴瘤、P-388 白血病和 P-815 肥大细胞瘤靶细胞具有细胞毒性和细胞生长抑制作用。然而,RPC-5 浆细胞瘤靶细胞似乎对其细胞毒性具有抗性。体外观察到的巨噬细胞的细胞毒性或细胞生长抑制作用与其产生超氧离子的能力无关。还研究了从经 pristane 预处理的小鼠获得的 NK 细胞的细胞毒性。未发现从经 pristane 处理和未处理的供体获得的 NK 细胞的细胞毒性有差异。然而,只有来自未处理小鼠的效应细胞能够对聚肌苷酸-聚胞苷酸-聚-L-赖氨酸(poly ICLC)的刺激作用作出反应。